EUVIMEDEUVIMED entdecken
Crossref

Mesenchymal stem cells—the master immunomodulators

Mehak Vohra, Sunil K. Arora

Exploration of Immunology · 27.04.2023 · 104-122

DOI: 10.37349/ei.2023.00092 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Exploration of Immunology, online erschienen am 27.04.2023. Verfasst von Mehak Vohra und 1 weiteren Autor:innen. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 100 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mesenchymal stem/stromal cells (MSCs) are known as multipotent cells due to their ability to differentiate into various cell lineages of mesoderm origin. Recent developments in stem cell biology have provided a new ray of hope for the treatment of diseases and disorders that are yet to be treated. These cells have been widely used in animals and clinical trials in humans. To date, there are more than 920 clinical trials on humans related to MSCs as cell-based therapy in various conditions. The purpose of this review is to provide a summary of the characteristics of MSCs, evaluate their immunological properties, activation of MSCs that dictate their soluble factors, possible pathway, and mechanisms involved by MSCs and immune cell interaction, and various application of MSCs in different diseases.

Zitieren

APA

Vohra, M., & Arora, S. K. (2023). Mesenchymal stem cells—the master immunomodulators. Exploration of Immunology, 104-122. https://doi.org/10.37349/ei.2023.00092

Vancouver

Vohra M, Arora SK. Mesenchymal stem cells—the master immunomodulators. Exploration of Immunology. 2023:104-122. doi:10.37349/ei.2023.00092

BibTeX
@article{Vohra2023,
  author = {Vohra, Mehak and Arora, Sunil K.},
  title = {Mesenchymal stem cells—the master immunomodulators},
  journal = {Exploration of Immunology},
  year = {2023},
  pages = {104--122},
  doi = {10.37349/ei.2023.00092}
}
Kostenlos starten →